ScoreCritical care
RESP score (survival on venovenous ECMO)
Estimates hospital survival in adults with severe acute respiratory failure treated with venovenous ECMO.
Updated 31 October 2026
When to use it
Before cannulation, using pre-ECMO data, to inform prognosis and benchmark outcomes between centres.
What it needs
- Age
- Immunocompromised
- Mechanical ventilation before ECMO
- Main acute respiratory diagnosis
- Central nervous system dysfunction
- Acute associated non-pulmonary infection
- Neuromuscular blockade before ECMO
- Inhaled nitric oxide before ECMO
- Bicarbonate infusion before ECMO
- Cardiac arrest before ECMO
- PaCO₂ before ECMO
- Peak inspiratory pressure before ECMO
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ -6 | Class V: estimated hospital survival ≈ 18 % |
| -5–-2 | Class IV: estimated hospital survival ≈ 33 % |
| -1–2 | Class III: estimated hospital survival ≈ 57 % |
| 3–5 | Class II: estimated hospital survival ≈ 76 % |
| ≥ 6 | Class I: estimated hospital survival ≈ 92 % |
Practical tip
It was derived in over 2300 ELSO registry patients (2000–2012); it does not apply to venoarterial ECMO or children.
3 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
